A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (Q73201224)
Jump to navigation
Jump to search
scientific article published on 26 February 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma |
scientific article published on 26 February 2003 |
Statements
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (English)
Stephen Y Chan
Alan N Gordon
Robert E Coleman
James B Hall
Mark S Berger
Matthew L Sherman
Catharine B Eten
26 February 2003